All In Biotech

Drug Trial Radar · NCT01842100

To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy

Last checked: Nov 19, 2026Latest source record: Apr 29, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 2,193 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,193

Actual

Start

Sep 1999

Primary completion

Feb 2006

Study completion Feb 2006

Sponsor

Lead sponsor
The University of Hong KongAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 29, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
Who can join
Female only
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Screen-and-treat approach reduces postabortal pelvic inflammatory disease after induced abortion, and at the same time alters women's sexual behavior and prevents further re-infection by sexually transmitted infections when compared to the universal antibiotic prophylaxis strategy.

Conditions

  • Induced Abortion
  • Postaboral Pelvic Inflammatory Disease
  • Sexually Transmitted Infections

Interventions

  • Universal antibiotic prophylaxisDrug

    100 mg twice daily for 7 days starting on the day of induced abortion

  • Screen-and-treatOther

    Specific antibiotic treatment was only given if the women was found to have sexually transmitted infection(s) on screening.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of postabortal inflammatory disease 6 weeks after induced abortion.Time frame: 6 weeks after induced abortion.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Queen Mary Hospital

    Hong Kong, Hong Kong, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.